Ballast Asset Management LP Raises Position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Ballast Asset Management LP lifted its stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 23.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 431,887 shares of the company's stock after purchasing an additional 82,187 shares during the quarter. Ballast Asset Management LP owned about 0.69% of Bioceres Crop Solutions worth $2,620,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Ping Capital Management Inc. boosted its holdings in Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after purchasing an additional 3,000 shares during the last quarter. Stifel Financial Corp lifted its holdings in Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after acquiring an additional 10,224 shares during the last quarter. JPMorgan Chase & Co. grew its position in Bioceres Crop Solutions by 17.0% in the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock worth $640,000 after acquiring an additional 15,328 shares during the period. Finally, Fourth Sail Capital LP grew its position in Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock worth $22,490,000 after acquiring an additional 527,859 shares during the period. Hedge funds and other institutional investors own 17.68% of the company's stock.

Analyst Ratings Changes

BIOX has been the topic of several recent analyst reports. Lake Street Capital decreased their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research note on Friday, February 7th. Canaccord Genuity Group reduced their price objective on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a report on Thursday, February 13th. Finally, Oppenheimer lowered their target price on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating for the company in a research note on Tuesday, January 28th. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of "Buy" and a consensus target price of $9.88.

Remove Ads

Bioceres Crop Solutions Trading Down 2.6 %

Shares of BIOX stock traded down $0.11 on Friday, hitting $4.13. The stock had a trading volume of 281,898 shares, compared to its average volume of 162,939. The company's 50 day moving average price is $5.01 and its 200-day moving average price is $6.26. Bioceres Crop Solutions Corp. has a 1 year low of $3.69 and a 1 year high of $13.18. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96. The firm has a market capitalization of $259.00 million, a P/E ratio of 206.60 and a beta of 0.73.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.